Semen as a rich source of diagnostic biomarkers for prostate cancer: latest evidence and implications
- 16 October 2021
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 477 (1) , 213-223
Abstract
Prostate cancer (PCa) is one of the most common cancers in men and the cause of numerous cancer deaths in the world. Nowadays, based on diagnostic criteria, prostate-specific antigen (PSA) evaluation and rectal examination are used to diagnose prostate-related malignancies. However, due to the different types of PCa, there are several doubts about the diagnostic value of PSA. On the other hand, semen is considered an appropriate source and contains various biomarkers in non-invasive diagnosing several autoimmune disorders and malignancies. Evidence suggests that analysis of semen biomarkers could be helpful in PCa diagnosis. Therefore, due to the invasiveness of most diagnostic methods in PCa, the use of semen as a biologic sample containing various biomarkers can lead to the emergence of novel and non-invasive diagnostic approaches. This review summarized recent studies on the use of various seminal biomarkers for diagnosis, prognosis and prediction of PCa.Keywords
Funding Information
- Zhejiang Provincial Natural Science Foundation of China (LQ19H160027)
This publication has 110 references indexed in Scilit:
- Genomic Medicine: New Frontiers and New ChallengesClinical Chemistry, 2013
- Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIMPLOS ONE, 2012
- Review of Small Cell Carcinomas of the ProstateProstate Cancer, 2011
- PC3 is a cell line characteristic of prostatic small cell carcinomaThe Prostate, 2011
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44Nature Medicine, 2011
- miR-21: an oncomir on strike in prostate cancerMolecular Cancer, 2010
- Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen EraJournal of Clinical Oncology, 2009
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- Preoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical ProstatectomyJNCI: Journal of the National Cancer Institute, 2006